KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecuritiesSecurities - Held-to-maturitySecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Home Bancshares (HOMB) Total Liabilities (2016 - 2025)

Home Bancshares has reported Total Liabilities over the past 10 years, most recently at $18.6 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $18.6 billion for Q4 2025, changed 0.3% from a year ago — trailing twelve months through Dec 2025 was $18.6 billion (changed 0.3% YoY), and the annual figure for FY2025 was $18.6 billion, changed 0.3%.
  • Total Liabilities for Q4 2025 was $18.6 billion at Home Bancshares, roughly flat from $18.5 billion in the prior quarter.
  • Over the last five years, Total Liabilities for HOMB hit a ceiling of $20.8 billion in Q2 2022 and a floor of $14.6 billion in Q1 2021.
  • Median Total Liabilities over the past 5 years was $18.7 billion (2025), compared with a mean of $18.0 billion.
  • Biggest five-year swings in Total Liabilities: skyrocketed 39.0% in 2022 and later fell 11.0% in 2023.
  • Home Bancshares' Total Liabilities stood at $15.3 billion in 2021, then increased by 26.63% to $19.4 billion in 2022, then fell by 2.54% to $18.9 billion in 2023, then fell by 1.78% to $18.5 billion in 2024, then increased by 0.3% to $18.6 billion in 2025.
  • The last three reported values for Total Liabilities were $18.6 billion (Q4 2025), $18.5 billion (Q3 2025), and $18.8 billion (Q2 2025) per Business Quant data.